Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Acadia Healthcare Company, Inc. (ACHC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ACHC at 36.7/100 on a 32-signal composite quality model, placing it at rank #2,260 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (11.5) and profitability (12.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Acadia Healthcare Company, Inc. reports quarterly revenue of $828.8M, net income of $4.1M, free cash flow of $-15.0M. Top institutional holders of ACHC by reported 13-F value include BlackRock, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. ACHC trades on the Nasdaq exchange and files with the SEC under CIK 1520697. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Acadia Healthcare Company, Inc. directly from SEC EDGAR.
AI Quality Score
36.7/100
AI Rank
#2,260
Revenue
$828.8M
Net Income
$4.1M
Free Cash Flow
$-15.0M
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $3.3B | $-1.1B | -32.2% |
| FY 2024 | 10-K | $3.2B | $255.6M | 10.8% |
| FY 2023 | 10-K | $2.9B | $-21.7M | -0.9% |
| FY 2022 | 10-K | $2.6B | $273.1M | 14.3% |
| FY 2021 | 10-K | $2.3B | $190.6M | 11.9% |
| FY 2020 | 10-K | $2.1B | $-672.1M | 8.8% |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| BlackRock | 14,957,168 | $441.7M | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 5,726,246 | $169.1M | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT | 5,369,461 | $158.6M | 2026-06-30 |
| FMR | 5,015,727 | $148.1M | 2026-06-30 |
| CARRONADE CAPITAL MANAGEMENT | 4,762,635 | $140.6M | 2026-06-30 |
| MORGAN STANLEY | 4,534,269 | $133.9M | 2026-06-30 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,520,000 | $133.5M | 2026-06-30 |
| DME Capital Management | 4,400,641 | $130.0M | 2026-06-30 |
| FARALLON CAPITAL MANAGEMENT | 4,220,800 | $124.6M | 2026-06-30 |
| ABRAMS BISON INVESTMENTS | 4,165,000 | $123.0M | 2026-06-30 |
13F Pro Quality Score
Rank #2,260 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk